ResultsIQ

ResultsIQ › Latest results › Vishnu Chemicals Limited

Vishnu Chemicals Limited Q3 FY26 earnings call summary

NSE: VISHNU · BSE: 516072

Earnings call of 6 Feb 2026, summarised by AI from the filing.

Vishnu Chemicals Q3 FY26 revenue ₹411.3 cr, EBITDA margin 15%; guides FY27 CAPEX ~₹300 cr and 20% EBITDA margin by FY28.

Key takeaways

  1. Change South Africa chrome ore mine acquisition completed; operations to start Q1 FY27.
  2. Driver Strontium Carbonate commercialized; approvals expected by Q4 FY26, sales from Q1 FY27.
  3. Risk Subdued global demand and elevated chrome ore prices impacted chromium segment EBITDA margins.

Original filing on BSE

Vishnu Chemicals Limited Q1 FY27 results

As filed: Revenue ₹433 cr (+25% year on year), EBITDA ₹65.5 cr (+19% year on year), PAT ₹39.6 cr (+24% year on year), EBITDA margin 15.1% (−74 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹450 cr (+15% year on year), EBITDA ₹76.7 cr (+22% year on year), PAT ₹43.4 cr (+11% year on year), EBITDA margin 17.0% (+100 bps). Score 56 of 100, In line with trend. Revenue and profit growth were in line with the company's own trend; EBITDA growth was above it. EBITDA margin rose 100 bps year on year. Share price after the results: +4.2% in 30 days (Nifty 500: +1.5%).
  • Q3 FY26: Revenue ₹411 cr (+11% year on year), EBITDA ₹61.7 cr (−2% year on year), PAT ₹33.8 cr (−1% year on year), EBITDA margin 15.0% (−197 bps). Score 43 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 197 bps year on year. Share price after the results: −1.4% in 30 days (Nifty 500: −1.1%).
  • Q2 FY26: Revenue ₹401 cr (+17% year on year), EBITDA ₹59.0 cr (+31% year on year), PAT ₹33.0 cr (+43% year on year), EBITDA margin 14.7% (+163 bps). Score 81 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 163 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Revenue rose ₹57.0 cr on a year ago, more than the ₹36.0 cr it added the year before. Share price after the results: −1.1% in 29 days (Nifty 500: +1.4%).
  • Q1 FY26: Revenue ₹347 cr (+2% year on year), EBITDA ₹55.0 cr (0% year on year), PAT ₹32.0 cr (+7% year on year), EBITDA margin 15.9% (−37 bps). Score 40 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin fell 37 bps year on year. Consolidated profit +7% but standalone -31%. Revenue fell 12% from last quarter. Share price after the results: −9.0% in 30 days (Nifty 500: +0.2%).
  • Q4 FY25: Revenue ₹393 cr (+31% year on year), EBITDA ₹63.0 cr (−2% year on year), PAT ₹39.0 cr (+39% year on year), EBITDA margin 16.0% (−530 bps). Score 56 of 100, In line with trend. Revenue and profit growth were well above the company's own trend; EBITDA growth was below it. EBITDA margin fell 530 bps year on year. Consolidated profit +39% but standalone -35%. Share price after the results: +18.6% in 29 days (Nifty 500: +0.5%).
  • Q3 FY25: Revenue ₹371 cr (+22% year on year), EBITDA ₹63.0 cr (+54% year on year), PAT ₹34.0 cr (+62% year on year), EBITDA margin 17.0% (+349 bps). Score 86 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 349 bps year on year. Consolidated profit +62% but standalone +0%.
  • Q2 FY25: Revenue ₹344 cr (+12% year on year), EBITDA ₹45.0 cr (−2% year on year), PAT ₹23.0 cr (−4% year on year), EBITDA margin 13.1% (−185 bps). Score 35 of 100, Below trend. EBITDA margin fell 185 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 23% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Vishnu Chemicals Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.